Orca Bio Competitors and Similar CompaniesClear all
Orca Bio's competitors and similar companies include Roivant Sciences, Taiwan Liposome, Sanofi Genzyme and Innovent Biologics.
 Orca Bio Orca Bio is a company that provides a medical therapy platform intended to develop cell therapies to increase the immunity of the human body. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 1997 | Founding Date 1981 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Menlo Park, US HQ | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Fangshan Qu, CN HQ |
Employees | Employees 1964% increase | Employees 908 | Employees 1652% decrease | Employees 9,9041% decrease | Employees 831 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($397.9m) (FY, 2025) | Net income (NT$983.3m) (FY, 2020) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 192m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 150m (about 8 years ago) |
Total funding raised | Total funding raised $ 300m | Total funding raised $ 1.9b | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 560m |
For sources of this data, please see the company profile
View Company Profiles
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View companyTaiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyInnovent Biologics
HQ
Fangshan Qu, CN
Employees
831
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
View company